Skip to Content
Merck
All Photos(1)

Documents

MAB1308

Sigma-Aldrich

Mouse Anti-Human IgG2 Antibody, clone HP6002, Fc

clone HP6002, Chemicon®, from mouse

Synonym(s):

Anti-Anti-CD32, Anti-Anti-CD32B, Anti-Anti-FCG2, Anti-Anti-FCGR2, Anti-Anti-FCGR2C, Anti-Anti-FcGRIIB, Anti-Anti-FcRII-c, Anti-Anti-FcgammaRIIb, Anti-Anti-IGFR2

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

UNSPSC Code:
12352203
eCl@ss:
32160702
NACRES:
NA.46

biological source

mouse

Quality Level

100

antibody form

purified immunoglobulin

antibody product type

secondary antibodies

clone

HP6002, monoclonal

species reactivity

human

manufacturer/tradename

Chemicon®

technique(s)

ELISA: suitable
radioimmunoassay: suitable
western blot: suitable

isotype

IgG1

NCBI accession no.

NM_001002273.1
NM_001002274.1
NM_001002275.1
NM_004001.3

UniProt accession no.

P31994

shipped in

wet ice

target post-translational modification

unmodified

Gene Information

human ... FCGR2B(2213)

Related Categories

Specificity

Human IgG2 Fc. ELISA Specificity: (Hamilton et al., 1987) human IgG subclass 1-0.02% human IgG subclass 2- 100% human IgG subclass 3- 0.01%

human IgG subclass 4- 0.01% Isoelectric Focusing: mean pI 7.1

Application

This Mouse anti-Human IgG2 Antibody, clone HP6002, Fc is validated for use in ELISA, RIA, WB for the detection of Human IgG2.
This antibody employed as both a capture antibody and a detection antibody for human IgG2 in enzyme linked immunosorbent assays, radio-immunoassay and EIA affinity immunoblots (Papadea et al., 1985; Hamilton, et al., 1987).

Final working dilutions must be determined by end user.

Linkage

Replaces: 411462-200UG

Physical form

Format: Purified
Purified Immunoglobulin. Liquid in 0.02M Phosphate buffer, pH=7.6, 0.25M NaCl containing 0.1% sodium azide.

Storage and Stability

Maintain at 2-8°C for up to one year in undiluted aliquots.

Other Notes

Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.

Legal Information

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

Not finding the right product?  

Try our Product Selector Tool.

Storage Class Code

10 - Combustible liquids

WGK

WGK 2

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Corine G Demanga et al.
Infection and immunity, 78(1), 486-494 (2009-11-04)
Plasmodium falciparum merozoite surface protein (MSP3) is a main target of protective immunity against malaria that is currently undergoing vaccine development. It was shown recently to belong, together with MSP6, to a new multigene family whose C-terminal regions have a
Subhash Singh et al.
The Journal of infectious diseases, 190(5), 1010-1018 (2004-08-06)
Merozoite surface protein 3 (MSP3) is a target of antibody-dependent cellular inhibition (ADCI), a protective mechanism against Plasmodium falciparum malaria. From the C-terminal half of the molecule, 6 overlapping peptides were chosen to characterize human immune responses. Each peptide defined
Suzanne E Barbour et al.
Infection and immunity, 70(6), 2780-2786 (2002-05-16)
Several lines of evidence indicate that the monocytes of subjects with localized juvenile periodontitis (LJP) are functionally distinct from cells of age- and race-matched nonperiodontitis (NP) subjects. Among the abnormalities are the propensity to secrete large amounts of prostaglandin E(2)
Elizabeth H Aitken et al.
eLife, 10 (2021-06-29)
Plasmodium falciparum causes placental malaria, which results in adverse outcomes for mother and child. P. falciparum-infected erythrocytes that express the parasite protein VAR2CSA on their surface can bind to placental chondroitin sulfate A. It has been hypothesized that naturally acquired
Katherine A McLaughlin et al.
Journal of immunology (Baltimore, Md. : 1950), 183(6), 4067-4076 (2009-08-19)
Multiple sclerosis (MS) typically manifests in early to mid adulthood, but there is increasing recognition of pediatric-onset MS, aided by improvements in imaging techniques. The immunological mechanisms of disease are largely unexplored in pediatric-onset MS, in part because studies have
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service